Novel appearance of hyperglycemia/diabetes, associated with COVID-19
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved..
In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of critically and non-critically ill patients with COVID-19, we found that indeed beta-cell function was compromised in critically ill patients with COVID-19 and that these patients showed a high glycemic gap. Nevertheless, one quarter of critically ill patients with no history of diabetes have stress hyperglycemia, a finding which could obscure the prevalence of hyperglycemia or new-onset diabetes that could be attributed to COVID-19 per se.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
World journal of virology - 11(2022), 2 vom: 25. März, Seite 111-112 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ilias, Ioannis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood glucose |
|---|
| Anmerkungen: |
Date Revised 19.04.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5501/wjv.v11.i2.111 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33962759X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33962759X | ||
| 003 | DE-627 | ||
| 005 | 20231226003325.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5501/wjv.v11.i2.111 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1132.xml |
| 035 | |a (DE-627)NLM33962759X | ||
| 035 | |a (NLM)35433337 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ilias, Ioannis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel appearance of hyperglycemia/diabetes, associated with COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of critically and non-critically ill patients with COVID-19, we found that indeed beta-cell function was compromised in critically ill patients with COVID-19 and that these patients showed a high glycemic gap. Nevertheless, one quarter of critically ill patients with no history of diabetes have stress hyperglycemia, a finding which could obscure the prevalence of hyperglycemia or new-onset diabetes that could be attributed to COVID-19 per se | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Blood glucose | |
| 650 | 4 | |a Hospitalization | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Hyperglycemia | |
| 650 | 4 | |a Pandemics | |
| 650 | 4 | |a Severe acute respiratory syndrome coronavirus 2 | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of virology |d 2012 |g 11(2022), 2 vom: 25. März, Seite 111-112 |w (DE-627)NLM232149992 |x 2220-3249 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:2 |g day:25 |g month:03 |g pages:111-112 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5501/wjv.v11.i2.111 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 2 |b 25 |c 03 |h 111-112 | ||